# Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD

> **NCT06215144** · PHASE2,PHASE3 · TERMINATED · sponsor: **Neurocentria, Inc.** · enrollment: 95 (actual)

## Conditions studied

- Attention-Deficit/Hyperactivity Disorder (ADHD)

## Interventions

- **DRUG:** NRCT-101SR

## Key facts

- **NCT ID:** NCT06215144
- **Lead sponsor:** Neurocentria, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-25
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-11-06
- **Target enrollment:** 95 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06215144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06215144, "Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT06215144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*